Mainz Biomed–SEVERAL: investment, 202111 IPO $10m with 2m common shares at $5/share at Nasdaq Capital Market |
2021-11-04 |
Cube Biotech–ArchiMed: investment, 202111 acquisition of majority stake by ArchiMed with founders remaining significant shareholders |
2021-11-03 |
Insilico Biotechnology–Yokogawa: investment, 202111 acquisition 100% of Insilico Biotechnology AG by Yokogawa Electric Corp |
2021-11-02 |
Pan Cancer T–Akampion: public relations, 202111 service existent by Akampion |
2021-10-28 |
Sartorius–Waters: biopharma production technology, 202110– collab product integration BioAccord LC-MS as bioprocess analyzer with Ambr bioreactor |
2021-10-27 |
Ajinomoto–Insilico Biotechnology: biopharma production technology, 202110– collab using digital twins to develop cell culture processes w Genexine |
2021-10-26 |
Exciva–Andera Partners: investment, 202110 financing round Series A totalling €9m incl lead investor Andera Partners |
2021-10-26 |
Exciva–Cure8: investment, 202110 financing round Series A totalling €9m incl co-investor Cure8 |
2021-10-26 |
Exciva–LBBW: investment, 202110 financing round Series A totalling €9m incl co-investor LBBW Venture Capital |
2021-10-26 |
Exciva–SEVERAL: investment, 202110 financing round Series A €9m led by Andera Partners |
2021-10-26 |
Ariceum Therapeutics–Ipsen: investment, 202010 Ipsen became shareholder by selling rights to satoreotide to Ariceum (then SatoSea Oncology GmbH) |
2021-10-22 |
Ariceum Therapeutics–Ipsen: satoreotide, 202010 acquisition of all rights from Ipsen which became shareholder of Ariceum (then SatoSea Oncology GmbH) |
2021-10-22 |
Emergence Therapeutics–Mablink Bioscience: ADC technology, 202110– license for use of PSARlink drug-linker to develop ADC targeting Nectin-4 |
2021-10-21 |
Leucid Bio–2Invest: investment, 202110 financing round Series A totalling £11.5m incl new + co-investor 2InvestAG |
2021-10-21 |
InflaRx–Germany (govt): grant, 202110– grant up to €43.7m from BMBF + BMG for developm of vilobelimab for Covid-19 |
2021-10-19 |
Abalos Therapeutics–SEVERAL: investment, 202110 financing round Series A extension €32.5m led by Seventure Partners |
2021-10-14 |
Computomics–Amathaon Capital: investment, 202110 acquisition €na of minority stake by Amathaon Capital |
2021-10-14 |
Computomics–Baden-Württemberg (govt): investment, 202110 existent seed investor MBG Mittelständische Beteiligungsgesellschaft Baden-Württemberg |
2021-10-14 |
Computomics–BASF: investment, 202110 acquisition €na of minority stake by BASF Venture Capital GmbH |
2021-10-14 |
VeroVaccines–SEVERAL: investment, 202110 financing round Series B mid-7-figure € from consortium of investors from Germany + Switzerland |
2021-10-14 |
Creapaper–eCapital: investment, 202110 financing round Series B totalling €20m incl existing investor eCapital |
2021-10-06 |
Creapaper–EU (govt): investment, 202110 financing round Series B totalling €20m incl new investor EIC Fund |
2021-10-06 |
Creapaper–JS Capital: investment, 202110 financing round Series B totalling €20m incl new investor JS Capital |
2021-10-06 |
Creapaper–Ranpak: investment, 202110 financing round Series B totalling €20m incl new investor Ranpak |
2021-10-06 |
Creapaper–Schusterman Family Investments: investment, 202110 financing round Series B totalling €20m incl new investor Schusterman Family Investments |
2021-10-06 |
Creapaper–SEVERAL: investment, 202110 financing round Series B €20m |
2021-10-06 |
Creapaper–Soros Capital: investment, 202110 financing round Series B totalling €20m incl new investor Soros Capital |
2021-10-06 |
Atbtherapeutics–Trophic Communications: public relations, 202110 service existent by Trophic Communications |
2021-10-05 |
Cellecta–Merck (DE): CRISPR technology, 202110– license for CRISPR-Cas9 technology to Cellecta |
2021-10-05 |
iOmx Therapeutics–SEVERAL: investment, 202110 financing round Series B €65m co-led by Athos Service GmbH + MIG Capital AG |
2021-10-05 |
Novartis–GSK: cephalosporin, 202110 acquisition of GSK’s global cephalosporins portfoloio by Sandoz |
2021-10-01 |
QInstruments–Bico: investment, 202110 acquisition 100% cash/debt free for €58.25m upfront + €3m milestones thereof 13% paid in new Bico shares |
2021-10-01 |
Isarna Therapeutics–Trophic Communications: public relations, 202109 service existent by Trophic Communications |
2021-09-30 |
Thermo Fisher–Carbon Engineering: analytical technology, 202109 collab existent direct air capture technology to reduce CO2 emissions |
2021-09-23 |
Biotest–Grifols: investment, 202109–202204 public cash tender offer €895m for remaining 54.5% of shares at €34/ordinary share + €37/preferred share |
2021-09-17 |
Creat (CN)–Grifols: investment, 202109 acquisition 100% of Tiancheng Germany owning 90% voting rights + 45% total capital of Biotest for €773m cash |
2021-09-17 |
BRAIN Biotech–SEVERAL: investment, 202109 capital increase €19.6m with 1.99m new shares at €9.85/share to institutional investors |
2021-09-15 |
Evotec–Biognosys: MS-based proteomics, 202109– collab integration of Spectronaut proteomics data analys into drug discovery + clinical proteomics |
2021-09-14 |
Roche–Temedica: digital companion, –202109 collab developm of digital companion app Brisa for MS patients by Temedica + Roche |
2021-09-14 |
Boehringer–Twist Bioscience: antibody drug discovery, 202109– collab using Twist Biopharma antibody phage display libraries against Boehringer targets |
2021-09-09 |
TIB Molbiol–Roche: investment, 202109–202112 acquisition 100% of TIB Mobiol Group by Roche |
2021-09-09 |
ImmunOs Therapeutics–Akampion: public relations, 202109 service existent by Akampion |
2021-09-01 |
Oviva–Earlybird: investment, 202109 financing round Series C totalling $80m incl existing + co-investor Earlybird |
2021-09-01 |
NürnbergMesse–Messe Stuttgart: T4M trade show, 202108 acquistion of T4M event from Messe Stuttgart by MedtecLIVE GmbH |
2021-08-30 |
Cardior Pharmaceuticals–ABP (NL): investment, 202108 financing round Series B totalling €64m incl new + lead investor Inkef Capital |
2021-08-25 |
Cardior Pharmaceuticals–BioMedPartners: investment, 202108 financing round Series B totalling €64m incl existing + co-investor BioMedPartners |
2021-08-25 |
Cardior Pharmaceuticals–BMS: investment, 202108 financing round Series B totalling €64m incl existing + co-investor BMS |
2021-08-25 |
Cardior Pharmaceuticals–Fund+: investment, 202108 financing round Series B totalling €64m incl new + co-investor Fund+ |
2021-08-25 |
Cardior Pharmaceuticals–Germany (govt): investment, 202108 financing round Series B totalling €64m incl new + co-investor Coparion |
2021-08-25 |
Cardior Pharmaceuticals–Hadean Ventures: investment, 202108 financing round Series B totalling €64m incl new + co-investor Hadean Ventures |
2021-08-25 |
Cardior Pharmaceuticals–High-Tech Gründerfonds: investment, 202108 financing round Series B totalling €64m incl existing + co-investor HTGF |
2021-08-25 |
Cardior Pharmaceuticals–Life Sciences Partners: investment, 202108 financing round Series B totalling €64m incl existing + co-investor LSP |
2021-08-25 |
Cardior Pharmaceuticals–SEVERAL: investment, 202108 financing round Series B €64m led by new investor Inkef Capital |
2021-08-25 |
Cardior Pharmaceuticals–Sunstone Life Science: investment, 202108 financing round Series B totalling €64m incl new + co-investor Sunstone |
2021-08-25 |
Cardior Pharmaceuticals–Trophic Communications: public relations, 202108 service existent by Trophic Communications |
2021-08-25 |
FarmInsect–5x Ventures: investment, 202108 2nd seed financing round totalling 7-digit € incl co-investor 5x Ventures |
2021-08-17 |
FarmInsect–Bavaria (govt): investment, 202108 2nd seed financing round totalling 7-digit € incl co-lead investor Bayern Kapital |
2021-08-17 |
FarmInsect–Genea Invest: investment, 202108 2nd seed financing round totalling 7-digit € incl co-investor Genea Invest |
2021-08-17 |
FarmInsect–High-Tech Gründerfonds: investment, 202108 2nd seed financing round totalling 7-digit € incl co-lead investor HTGF |
2021-08-17 |
FarmInsect–Industrial Innovators Initiative: investment, 202108 2nd seed financing round totalling 7-digit € incl co-investor III |
2021-08-17 |
FarmInsect–OTHER: investment, 202108 2nd seed financing round totalling 7-digit € incl business angels as co-investors |
2021-08-17 |
FarmInsect–SEVERAL: investment, 202108 2nd seed financing round 7-digit € co-led by HTGF + Bayern Kapital |
2021-08-17 |
Bayer–Berkeley Lights: plant research, 202108 collab multi-year €na RnD seeds and traits using Berkeley Lights Platform |
2021-08-11 |
Vividion Therapeutics–Bayer: investment, 202108– acquisition $1.5b upfront + $500k milestones |
2021-08-05 |
Evotec–SEVERAL: investment, 202108–202111 public offering $435m+$65.14m with 20m+2.995m ADSs at $21.75/ADS US listing at Nasdaq |
2021-08-02 |
Topas Therapeutics–BioMedPartners: investment, 202107 financing round Series B extension €18m incl existing investor BioMedPartners |
2021-07-29 |
Topas Therapeutics–Boehringer: investment, 202107 financing round Series B extension €18m incl existing investor BIVF |
2021-07-29 |
Topas Therapeutics–EMBL: investment, 202107 financing round Series B extension €18m incl existing investor EMBL Ventures |
2021-07-29 |
Topas Therapeutics–Epidarex Capital: investment, 202107 financing round Series B extension €18m incl existing investor Epidarex Capital |
2021-07-29 |
Topas Therapeutics–Evotec: investment, 202107 financing round Series B extension €18m incl existing investor Evotec |
2021-07-29 |
Topas Therapeutics–Gimv: investment, 202107 financing round Series B extension €18m incl existing investor Gimv |
2021-07-29 |
Topas Therapeutics–SEVERAL: investment, 202107 financing round Series B extension €18m bringing total round to €40m incl all existing investors |
2021-07-29 |
Topas Therapeutics–Vesalius Biocapital: investment, 202107 financing round Series B extension €18m incl existing investor Vesalius Biocapital III |
2021-07-29 |
Xell AG–Sartorius: investment, 202107 acquisition €50m plus two revenue-based earn-out components in 2022 to 2025 |
2021-07-29 |
HMNC–SEVERAL: credit, 202107 convertible debt financing €9m from renowned family offices incl Maschmeyer + Jahr + Gutmann |
2021-07-28 |
Nuvisan–ALS Ltd: investment, 202207 strategic investment acquiring 49% stake in Nuvisan to expand ALS Life Sciences network |
2021-07-28 |
Sartorius–BRAIN Biotech: genome editing technology, 202107– collab research on CRISPR Cas-nucleases (BECs) |
2021-07-28 |
Cevec–North Rhine-Westphalia (govt): investment, 202107 growth financing round incl investor NRW.Bank |
2021-07-27 |
Cevec–SEVERAL: investment, 202107 growth financing round with investor NRW.Bank et al |
2021-07-27 |
3a-Diagnostics–XPhyto Therapeutics: investment, 202107– 202110 acqisition 100% €400k upfront + €3.5m at closing ANNOUNCED |
2021-07-20 |
BioNTech–Gilead: cell therapy, 202107– acquisition €na of Kite’s solid tumor neoantigen TCR RnD platform + clinical manufacturing facility |
2021-07-19 |
Holtzbrinck–OntoChem: information services, 202107– collab of OntoChem with Dimensions part of Digital Science |
2021-07-15 |
Dopavision–Akampion: public relations, 202107 service existent by Akampion |
2021-07-14 |
Dopavision–Boehringer: investment, 202107 financing round Series A totalling €12m incl existing + co-investor BIVF |
2021-07-14 |
Dopavision–BPCE: investment, 202107 financing round Series A totalling €12m incl new + lead investor Seventure Partners |
2021-07-14 |
Dopavision–Eternity.Health: investment, 202107 financing round Series A totalling €12m incl existing + co-investor Ababax Health |
2021-07-14 |
Dopavision–Novartis: investment, 202107 financing round Series A totalling €12m incl new + co-investor Novartis Pharmaceuticals |
2021-07-14 |
Dopavision–SEVERAL: investment, 202107 financing round Series A €12m led by new investor Seventure Partners |
2021-07-14 |
InfanDx–SEVERAL: investment, 202107 financing round Series A first closing €4m from new investor Alluti GmbH + existing investors |
2021-07-13 |
Cutanos–High-Tech Gründerfonds: investment, 202107 1st financing round incl investor HTGF |
2021-07-05 |
Cutanos–Khanu Management: investment, 202107 1st financing round incl investor KHAN Technology Transfer Fund I |
2021-07-05 |
CellGenix–Sartorius: investment, 202107 acquisition 51% share for €100m cash by SSB with planned acquisition of remaining shares until 2026 |
2021-07-02 |
Zukunftsfonds Heilbronn–Ampersand: investment, 202107 acquisition of majority share in PPS from ZFHN and merger with portfolio company GeneWerk |
2021-07-01 |
Boehringer–WPP: public releations, 202106c supply service Boehringer is among largest + long-term health clients of Ogilvy Health |
2021-06-28 |
Electrochaea–Baker Hughes: investment, 202106–202201 financing round Series D totalling €36m incl lead investor Baker Hughes |
2021-06-28 |
Electrochaea–EU (govt): investment, 202106–202201 financing round Series D totalling €36m incl €14.9m from co-lead investor EIC Fund |
2021-06-28 |
Electrochaea–SEVERAL: investment, 202106–202201 financing round Series D €36m led by Baker Hughes + co-led by EIC Fund |
2021-06-28 |
Merck (DE)–Nucleai MD: AI-based biomarker discovery, 202106– long-term collab using ATOM platform for cancer biomarker discovery |
2021-06-24 |
RheinCell Therapeutics–Catalent: investment, 202106– acquisition of RheinCell by Catalent ANNOUNCED |
2021-06-24 |
FundaMental Pharma–High-Tech Gründerfonds: investment, 202106 seed funding from HTGF |
2021-06-23 |